Skip to content

Clinical efficacy of subcutaneous subcision combined with adipose component transplantation and skin radiofrequency in the treatment of atrophic acne scars

Clinical efficacy of subcutaneous subcision combined with adipose component transplantation and skin radiofrequency in the treatment of atrophic acne scars

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115134
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrophic scars

Interventions

Subcutaneous scar dissection combined with differentiated fat filling and skin radiofrequency therapy group:NA

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary signing of the informed consent form; 2. Age >= 18 years old; 3. Gender: Male or female; 4. Patients diagnosed with acne atrophic scars in accordance with the "Procedural and surgical treatment modalities for acne scarring" guidelines published in the Journal of the American Academy of Dermatology in 2024; 5. Patients with a history of facial atrophic scars for 6 months or more and who have not received other acne scar treatments within 6 months prior to enrollment; 6 .Patients who, according to the judgment of the treating physician, need to receive "subcutaneous dissection combined with componentized fat transplantation and skin radiofrequency treatment". 7. Patients with acne atrophic scars who received "subcutaneous subcision combined with adipose component transplantation and microneedling radiofrequency" treatment at our hospital from April 2024 to April 2025.

Exclusion criteria

Exclusion criteria: 1. There is an infection on the facial skin, and the person has a bleeding disorder or a photosensitive disease; 2. Keloid-prone constitution; 3. Combined with other serious heart, liver and kidney diseases; 4. The researcher judged that it was not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
The recovery of acne atrophic scars;

Secondary

MeasureTime frame
Improvement of acne atrophic scars;

Countries

China

Contacts

Public ContactXihang Chen

Southern Medical University Southern Hospital

515442569@qq.com+86 20 62786487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026